Cerenome, Inc. (CNSY)

0.6699 -0.22 (-24.87%) USD  |  NASDAQ  |  Nov 05, 16:00
0.6541 -0.02 (-2.36%) After-Hours: 06:02
More

Cerenome SG&A Expense (TTM) : 18.10M for June 30, 2026

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 18.10M
March 31, 2026 14.58M
December 31, 2025 12.13M
September 30, 2025 11.09M
June 30, 2025 10.04M
March 31, 2025 10.56M
December 31, 2024 9.939M
September 30, 2024 9.192M
June 30, 2024 8.793M
March 31, 2024 8.514M
December 31, 2023 8.544M
September 30, 2023 9.75M
June 30, 2023 9.974M
March 31, 2023 10.34M
December 31, 2022 10.24M
September 30, 2022 8.694M
June 30, 2022 8.462M
March 31, 2022 7.642M
December 31, 2021 6.853M
September 30, 2021 7.11M
June 30, 2021 6.18M
March 31, 2021 6.14M
December 31, 2020 6.406M
September 30, 2020 5.779M
June 30, 2020 5.889M
Date Value
March 31, 2020 5.432M
December 31, 2019 5.291M
September 30, 2019 4.606M
June 30, 2019 4.891M
March 31, 2019 5.397M
December 31, 2018 6.842M
September 30, 2018 7.987M
June 30, 2018 9.157M
March 31, 2018 11.06M
December 31, 2017 11.19M
September 30, 2017 11.86M
June 30, 2017 12.06M
March 31, 2017 11.90M
December 31, 2016 12.17M
September 30, 2016 12.07M
June 30, 2016 12.18M
March 31, 2016 12.41M
December 31, 2015 12.43M
September 30, 2015 13.63M
June 30, 2015 16.34M
March 31, 2015 19.43M
December 31, 2014 22.36M
September 30, 2014 24.83M
June 30, 2014 25.30M
March 31, 2014 25.22M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. 1.338B
Ernexa Therapeutics, Inc. 5.319M
ACADIA Pharmaceuticals, Inc. 486.89M
Anika Therapeutics, Inc. 52.67M
Savara, Inc. 56.71M